Comparative sensitivity of prognostic markers in relation to aggressive types of acute myeloid leukemia and myelodysplastyic syndrome : A retrospective study /
Ahmed Asaad Abdelmegeed
Comparative sensitivity of prognostic markers in relation to aggressive types of acute myeloid leukemia and myelodysplastyic syndrome : A retrospective study / مقارنة لحساسية الدالات التوقيعية فى علاقتها بالانواع العنيفة من سرطان الدم الميلودى ومرض سوء النمو النخاعى Ahmed Asaad Abdelmegeed ; Supervised Heba M.Rabia Alzawahry , Farida H.Gadallah , Khaled M.Aboulenein - Cairo : Ahmed Asaad Abdelmegeed , 2007 - 218P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology
This study included 40 cases of AML and MDS patients the prognostic importance of genetic events is mostly clearly demonstrated in the acute myeloid leukemias characterized by recurrent chromosome translocations : T (15 , 17) (q22 , q12) , T (8 , 21) (q22 , q22) and inv 16 (p13 , q22) which generally have a favorable prognosis when treated with a appropriate therapeutic agents
Acute myeloid leukemia Myelodysplastyic Syndrome Prognostic Markers
Comparative sensitivity of prognostic markers in relation to aggressive types of acute myeloid leukemia and myelodysplastyic syndrome : A retrospective study / مقارنة لحساسية الدالات التوقيعية فى علاقتها بالانواع العنيفة من سرطان الدم الميلودى ومرض سوء النمو النخاعى Ahmed Asaad Abdelmegeed ; Supervised Heba M.Rabia Alzawahry , Farida H.Gadallah , Khaled M.Aboulenein - Cairo : Ahmed Asaad Abdelmegeed , 2007 - 218P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology
This study included 40 cases of AML and MDS patients the prognostic importance of genetic events is mostly clearly demonstrated in the acute myeloid leukemias characterized by recurrent chromosome translocations : T (15 , 17) (q22 , q12) , T (8 , 21) (q22 , q22) and inv 16 (p13 , q22) which generally have a favorable prognosis when treated with a appropriate therapeutic agents
Acute myeloid leukemia Myelodysplastyic Syndrome Prognostic Markers